Challenges in the management of bipolar depression

Journal of Clinical Psychiatry

Volumn 66, Issue SUPPL. 5, 2005, Pages 11-16

  Suppes, Trisha ^a   Kelly, Dorothy I ^a   Perla, Jessica M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; FLUOXETINE PLUS OLANZAPINE; LAMOTRIGINE; LITHIUM; LITHIUM CARBONATE; OLANZAPINE; QUETIAPINE;

ANXIETY DISORDER; BIPOLAR DEPRESSION; CLINICAL RESEARCH; COMORBIDITY; CONFERENCE PAPER; DEPRESSION; DIAGNOSTIC ACCURACY; DRUG CHOICE; HUMAN; LONG TERM CARE; MAJOR DEPRESSION; PRIORITY JOURNAL; RISK ASSESSMENT; SUICIDE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; ANTICONVULSANTS; BIPOLAR DISORDER; COMBINED MODALITY THERAPY; COMORBIDITY; FEMALE; HUMANS; LIFE CHANGE EVENTS; LITHIUM; MALE; PATIENT EDUCATION; PSYCHOTHERAPY; SEX FACTORS; TRIAZINES;

EID: 21644481018     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (61)

1. Hirschfeld RMA, Calabrese JR, Weissman MM, et al. Screening for bipolar disorder in the community. J Clin Psychiatry 2003;64:53-59
2. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990;264:2511-2518
3. Regeer EJ, ten Have M, Rosso ML, et al. Prevalence of bipolar disorder in the general population: a Reappraisal Study of the Netherlands Mental Health Survey and Incidence Study. Acta Psychiatr Scand 2004;110: 374-382
4. Suppes T, Leverich GS, Keck PE, et al. The Stanley Foundation Bipolar Treatment Outcome Network: demographics and illness characteristics ; of the first 261 patients. J Affect Disord 2001;67:45-49
5. Hirschfeld RMA, Lewis L, Vomik LA. Perceptions and impact of bipolar disorder: how far have we really come? results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry 2003;64:161-174
6. Post RM, Leverich GS, Altshuler LL, et al. An overview of recent findings of the Stanley Foundations Bipolar Network, pt 1. Bipolar Disord 2003;5:310-319
7. Judd LL, Akiskal HS, Schettler PJ, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002;59:530-537
8. Judd LL, Akiskal HS, Schettler PJ, et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 2003;60:261-269
9. Simpson SG, Jamison KR. The risk of suicide in patients with bipolar disorders. J Clin Psychiatry 1999;60(suppl 2):53-56
10. Altshuler LL, Gitlin MJ, Mintz J, et al. Subsyndromal depression is associated with functional impairment in patients with bipolar disorder. J Clin Psychiatry 2002;63:807-811
11. Calabrese JR, Hirschfeld RMA, Reed M, et al. Impact of bipolar disorder on a US community sample. J Clin Psychiatry 2003;64:425-432
12. Hlastala SA, Frank E, Mallinger AG, et al. Bipolar depression: an underestimated treatment challenge. Depress Anxiety 1997;5:73-83
13. Dunner DL. Clinical consequences of under-recognized bipolar spectrum disorder. Bipolar Disord 2003;5:456-463
14. Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 1992;149:999-1010
15. Swann AC, Bowden CL, Morris D, et al. Depression during mania: treatment response to lithium or divalproex. Arch Gen Psychiatry 1997;54: 37-42
16. Manning JS. Bipolar disorder in primary care. Curr Psychiatry 2003; (suppl):6-9
17. Hirschfeld RMA, Williams JB, Spitzer RL, et al. Development and validation of a screening instrument for bipolar disorder: the Mood Disorder Questionnaire. Am J Psychiatry 2000;157:1873-1875
18. American Psychiatric Association. Practice Guidelines for the Treatment of Patients With Bipolar Disorder [Revision]. Am J Psychiatry 2002;159 (suppl 4):1-50
19. Suppes T, Dennehy EB, Swann AC. Report of the Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder 2000. J Clin Psychiatry 2002;63:288-299
20. Goodwin GM, Young AH. The British Association for Psychopharmacology guidelines for treatment of bipolar disorder: a summary. J Psychopharmacol 2003;17:3-6
21. Grunze H, Kasper S, Goodwin G, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders, pt 2: treatment of bipolar depression. World J Biol Psychiatry 2002;3:115-124
22. Keck PE, Perils RH, Otto MW, et al. The Expert Consensus Guideline Series: Treatment of Bipolar Disorder 2004. Postgrad Med 2004:1-122
23. Altshuler LL, Post RM, Leverich GS, et al. Antidepressant-induced manic and cyclic acceleration: a controversy revisited. Am J Psychiatry 1995;152: 1130-1138
24. Goldberg JF, Truman CJ. Antidepressant-induced mania: an overview of current controversies. Bipolar Disord 2003;5:407-420
25. Baldessarini RJ, Tondo L, Hennen J, et al. Is lithium still worth using? an update of selected recent research. Harv Rev Psychiatry 2002;10:59-75
26. Thase ME, Sachs GS. Bipolar depression: pharmacotherapy and related therapeutic strategies. Biol Psychiatry 2000;48:558-572
27. Ghaemi SN, Sachs GS, Goodwin FK. What is to be done? controversies in the diagnosis and treatment of manic-depressive illness. World J Biol Psychiatry 2000;1:65-74
28. Grunze H. Reevaluating therapies for bipolar depression. J Clin Psychiatry 2005;66(suppl 5):17-25
29. Calabrese JR, Bowden CL, Sachs GS, et al. A double-blind, placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry 1999;60:79-88
30. Bowden CL, Calabrese JR, Sachs G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003;60: 392-400
31. Calabrese JR, Bowden CL, Sachs G, et al, for the Lamictal 605 Study Group. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder [Comment in: Evid Based Ment Health 2004;7:48]. J Clin Psychiatry 2003;64:1013-1024
32. Tohen M, Vieta E, Calabrese J, et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 2003;60:1079-1088
33. Calabrese JR, Keck PE Jr, MacFadden W, et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry. In press
34. Calabrese JR, Elhaj O, Gajwani P, et al. Clinical highlights in bipolar depression: focus on atypical antipsychotics. J Clin Psychiatry 2005; 66(suppl 5):26-33
35. Suppes T, Dennehy EB, Hirschfeld RMA, et al. The Texas Implementation of Medication Algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry. In press
36. Hammen C, Gitlin M. Stress reactivity in bipolar patients and its relation to prior history of disorder. Am J Psychiatry 1997;154:856-857
37. Hlastala SA, Frank E, Kowalski J, et al. Stressful life events, bipolar disorder, and the "kindling model." J Abnormal Psychol 2000;109:777-786
38. Hlastala SA. Stress, social rhythms, and behavioral activation: psychosocial factors and the bipolar illness course. Curr Psychiatry Rep 2003;5:477-483
39. Christensen EM, Gjerris A, Larsen JK, et al. Life events and onset of a new phase in bipolar affective disorder. Bipolar Disord 2003;5:356-361
40. Kessing LV, Agerbo E, Mortensen PB. Major stressful life events and other risk factors for first admission with mania. Bipolar Disord 2004;6:122-129
41. Vieta E. The package of care for patients with bipolar depression. J Clin Psychiatry 2005;66(suppl 5):34-39
42. Calabrese JR, Vieta E, El-Mallakj R, et al. Mood state at study entry as predictor of risk of relapse and spectrum of efficacy in bipolar maintenance studies. Biol Psychiatry 2004;56:857-873
43. Judd LL, Akiskal HS, Schettler PJ, et al. The comparative clinical phenotype and long term longitudinal episode course of bipolar I and II: a clinical spectrum or distinct disorders? J Affect Disord 2003;73:19-32
44. Suppes T, Dennehy EB. Evidence-based long-term treatment of bipolar II disorder. J Clin Psychiatry 2002;63(suppl 10):29-33
45. Vieta E, Gasto C, Otero A, et al. Differential features between bipolar I and bipolar II disorder. Compr Psychiatry 1997;38:98-101
46. Suppes T, Mintz J, McElroy SL, et al. Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Bipolar Treat-ment Network: a gender-specific phenomenon. Arch Gen Psychiatry. In press
47. Freeman MP, Freeman SA, McElroy SL. The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues. J Affect Disord 2002;68:1-23
48. Henry C, Van den Bulke D, Bellivier F, et al. Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer. J Clin Psychiatry 2003;64:331-335
49. Frye MA, Altshuler LL, McElroy SL, et al. Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder. Am J Psychiatry 2003;160:883-889
50. McElroy SL, Altshuler LL, Suppes T, et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry 2001;158:420-426
51. Sasson Y, Chopra M, Harrari E, et al. Bipolar comorbidity: from diagnostic dilemmas to therapeutic challenge. Int J Neuropsychopharmacol 2003;6: 139-144
52. Hendrick V, Altshuler LL, Gitlin MJ, et al. Gender and bipolar illness. J Clin Psychiatry 2000;61:393-396
53. Arnold LM. Gender differences in bipolar disorder. Psychiatr Clin North Am 2003;26:595-620
54. Benazzi F. Gender differences in bipolar II and unipolar depressed outpatients: a 557-case study. Ann Clin Psychiatry 1999;11:55-59
55. Coryell W, Endicott J, Keller M. Rapid cycling affective disorder: demographics, diagnosis, family history, and course. Arch Gen Psychiatry 1992;49:126-131
56. Tondo L, Baldessarini RJ. Rapid cycling in women and men with bipolar manic-depressive disorders. Am J Psychiatry 1998;155:1434-1436
57. Calabrese JR, Shelton MD, Bowden CL, et al. Bipolar rapid cycling: focus on depression as its hallmark. J Clin Psychiatry 2001;62(suppl 14):34-41
58. Grunze H, Amann B, Dittmann S, et al. Clinical relevance and treatment possibilities of bipolar rapid cycling. Neuropsychobiology 2002;45 (suppl 1):20-26
59. Calabrese JR, Shelton MD, Rapport DJ, et al. A 20-month, double-blind, maintenance trial of lithium vs divalproex in rapid-cycling bipolar disorder. Am J Psychiatry. In press
60. Coryell W, Solomon D, Turvey C, et al. The long-term course of rapid-cycling bipolar disorder. Arch Gen Psychiatry 2003;60:914-920
61. Vieta E, Calabrese JR, Macfadden W, et al. Quetiapine for the treatment of rapid-cycling bipolar depression [abstract]. Acta Psychiatr Scand 2004; 110(suppl):41